These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1968754)

  • 21. Beta2-adrenoceptor polymorphism and bronchoprotective sensitivity with regular short- and long-acting beta2-agonist therapy.
    Lipworth BJ; Hall IP; Aziz I; Tan KS; Wheatley A
    Clin Sci (Lond); 1999 Mar; 96(3):253-9. PubMed ID: 10029561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of the onset of action of salbutamol and formoterol in reversing methacholine-induced bronchoconstriction.
    van Noord JA; Smeets JJ; Maesen FP
    Respir Med; 1998 Dec; 92(12):1346-51. PubMed ID: 10197228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formoterol delivered by Turbuhaler: in pediatric asthma.
    Cheer SM; Warner GT; Easthope SE
    Paediatr Drugs; 2003; 5(1):63-8; discussion 69. PubMed ID: 12513109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonbronchodilator effects of inhaled beta 2 agonists. Greater protection against adenosine monophosphate- than methacholine-induced bronchoconstriction in asthma.
    O'Connor BJ; Fuller RW; Barnes PJ
    Am J Respir Crit Care Med; 1994 Aug; 150(2):381-7. PubMed ID: 8049819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Actions other than smooth muscle relaxation may play a role in the protective effects of formoterol on the allergen-induced late asthmatic reaction.
    Brusasco V; Crimi E; Gherson G; Nardelli R; Oldani V; Francucci B; Della Cioppa G; Senn S; Fabbri LM
    Pulm Pharmacol Ther; 2002; 15(4):399-406. PubMed ID: 12220946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of inhaled formoterol in reversing bronchoconstriction.
    Rubin AS; Perin C; Pelegrin L; Fernandes JC; da Silva LC
    J Bras Pneumol; 2006; 32(3):202-6. PubMed ID: 17273608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regular inhaled beta agonist in asthma: effects on exacerbations and lung function.
    Taylor DR; Sears MR; Herbison GP; Flannery EM; Print CG; Lake DC; Yates DM; Lucas MK; Li Q
    Thorax; 1993 Feb; 48(2):134-8. PubMed ID: 8493626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the effects of salmeterol and formoterol on airway tone and responsiveness over 24 hours in bronchial asthma.
    Rabe KF; Jörres R; Nowak D; Behr N; Magnussen H
    Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1436-41. PubMed ID: 8503554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.
    Cheung D; Timmers MC; Zwinderman AH; Bel EH; Dijkman JH; Sterk PJ
    N Engl J Med; 1992 Oct; 327(17):1198-203. PubMed ID: 1357550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effect of formoterol on adenosine monophosphate and histamine reactivity in asthma.
    Nightingale JA; Rogers DF; Barnes PJ
    Am J Respir Crit Care Med; 1999 Jun; 159(6):1786-90. PubMed ID: 10351919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of formoterol on histamine induced plasma exudation in induced sputum from normal subjects.
    Greiff L; Wollmer P; Andersson M; Svensson C; Persson CG
    Thorax; 1998 Dec; 53(12):1010-3. PubMed ID: 10195069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term effects of formoterol and salbutamol on bronchial hyperreactivity and beta-adrenoceptor density on lymphocytes in children with bronchial asthma.
    Kozlik-Feldmann R; von Berg A; Berdel D; Reinhardt D
    Eur J Med Res; 1996 Jul; 1(10):465-70. PubMed ID: 9438143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of an inhaled glucocorticosteroid on mast cell and smooth muscle beta 2 adrenergic tolerance in mild asthma.
    Yates DH; Worsdell M; Barnes PJ
    Thorax; 1998 Feb; 53(2):110-3. PubMed ID: 9624295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of prior treatment with salmeterol and formoterol on airway and systemic beta 2 responses to fenoterol.
    Grove A; Lipworth BJ
    Thorax; 1996 Jun; 51(6):585-9. PubMed ID: 8693438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of inhaled formoterol versus terbutaline on respiratory function in moderate bronchial asthma.
    Hedenström H; Wegener T; Boman G; Wåhlander L; Melander B
    Allergy; 1992 Apr; 47(2 Pt 2):158-63. PubMed ID: 1514666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formoterol thrice weekly does not result in the development of tolerance to bronchoprotection.
    Davis BE; Reid JK; Cockcroft DW
    Can Respir J; 2003; 10(1):23-6. PubMed ID: 12650133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can asthma treatment in sports be doping? The effect of the rapid onset, long-acting inhaled beta2-agonist formoterol upon endurance performance in healthy well-trained athletes.
    Carlsen KH; Hem E; Stensrud T; Held T; Herland K; Mowinckel P
    Respir Med; 2001 Jul; 95(7):571-6. PubMed ID: 11453313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence of the rapid protective effect of formoterol dry-powder inhalation against exercise-induced bronchospasm in athletes with asthma.
    Ferrari M; Balestreri F; Baratieri S; Biasin C; Oldani V; Lo Cascio V
    Respiration; 2000; 67(5):510-3. PubMed ID: 11070454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid onset of action of inhaled formoterol in asthmatic patients.
    Wegener T; Hedenström H; Melander B
    Chest; 1992 Aug; 102(2):535-8. PubMed ID: 1353718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the relative efficacy of formoterol and salmeterol in asthmatic patients.
    Palmqvist M; Ibsen T; Mellén A; Lötvall J
    Am J Respir Crit Care Med; 1999 Jul; 160(1):244-9. PubMed ID: 10390407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.